Notify me when Samsara BioCapital, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 27 | $766M | +$46.6M | -$46.5M | +$144K | MLYS, SRRK, KLRS, SEPN, NGNE | 13F-HR | 11/14/2025, 04:29 PM |
| Q2 2025 | 29 | $489M | +$16.5M | -$53.4M | -$36.9M | SRRK, MLYS, SEPN, KLRS, NGNE | 13F-HR | 8/14/2025, 04:44 PM |
| Q1 2025 | 37 | $561M | +$106M | -$60.6M | +$45.8M | SRRK, KLRS, MLYS, NGNE, ALMS | 13F-HR | 5/15/2025, 04:14 PM |
| Q4 2024 | 43 | $729M | +$130M | -$80.1M | +$50M | SRRK, CRGX, SEPN, MLYS, NGNE | 13F-HR | 2/14/2025, 05:17 PM |
| Q3 2024 | 42 | $520M | +$41.4M | -$18.8M | +$22.6M | CRGX, MLYS, SRRK, NGNE, ALMS | 13F-HR | 11/14/2024, 04:15 PM |
| Q2 2024 | 40 | $478M | +$57M | -$32.3M | +$24.7M | CRGX, MLYS, SRRK, NGNE, ACLX | 13F-HR | 8/14/2024, 04:17 PM |
| Q1 2024 | 39 | $646M | +$67.8M | -$150M | -$82M | SRRK, CRGX, MLYS, NGNE, NKTX | 13F-HR | 5/15/2024, 04:16 PM |
| Q4 2023 | 41 | $643M | +$179M | -$38.6M | +$141M | SRRK, RYZB, CRGX, MLYS, ACLX | 13F-HR | 2/14/2024, 04:29 PM |
| Q3 2023 | 41 | $327M | +$60.3M | -$226M | -$166M | MLYS, RYZB, SRRK, SLRN, ACLX | 13F-HR | 11/14/2023, 04:15 PM |
| Q2 2023 | 47 | $570M | +$53.2M | -$62.5M | -$9.3M | KDNY, MLYS, SLRN, SRRK, GRPH | 13F-HR | 8/14/2023, 04:58 PM |
| Q1 2023 | 56 | $484M | +$99.3M | -$20.5M | +$78.8M | KDNY, MLYS, SRRK, ACLX, GRPH | Restatement | 8/14/2023, 04:57 PM |
| Q4 2022 | 1 | $3.16M | $0 | $0 | SYRS | New Holdings | 2/15/2023, 05:03 PM | |
| Q4 2022 | 54 | $464M | +$26.9M | -$69.6M | -$42.7M | KDNY, SRRK, ACLX, GRPH, VRNA | 13F-HR | 2/14/2023, 04:43 PM |
| Q3 2022 | 55 | $428M | $0 | -$30.5M | -$30.5M | KDNY, NKTX, SRRK, GRPH, FMTX | 13F-HR | 11/14/2022, 04:03 PM |
| Q2 2022 | 56 | $374M | +$71.3M | -$13.7M | +$57.6M | KDNY, NKTX, SRRK, GRPH, ACLX | 13F-HR | 8/15/2022, 04:00 PM |
| Q1 2022 | 56 | $395M | +$48.7M | -$4.92M | +$43.8M | KDNY, GRPH, NKTX, TIL, ISEE | 13F-HR | 5/16/2022, 04:13 PM |
| Q4 2021 | 49 | $502M | +$46.8M | -$14.4M | +$32.3M | GRPH, KDNY, TIL, NKTX, STRO | 13F-HR | 2/14/2022, 02:32 PM |
| Q3 2021 | 46 | $602M | +$16.8M | -$30.9M | -$14.1M | GRPH, NKTX, KDNY, TIL, FMTX | 13F-HR | 11/15/2021, 04:32 PM |
| Q2 2021 | 48 | $761M | +$362M | -$27.8M | +$334M | GRPH, NKTX, KDNY, TIL, FMTX | 13F-HR | 8/16/2021, 09:08 PM |
| Q1 2021 | 42 | $497M | +$110M | -$41.3M | +$69M | NKTX, KDNY, FMTX, TIL, STRO | 13F-HR | 5/17/2021, 06:06 PM |
| Q4 2020 | 43 | $487M | +$88.3M | -$80M | +$8.25M | NKTX, KDNY, FMTX, STRO, SYRS | 13F-HR | 2/16/2021, 07:12 PM |
| Q3 2020 | 36 | $359M | +$136M | -$79.2M | +$57.2M | FMTX, NKTX, ISEE, SWTX, CVAC | 13F-HR | 11/16/2020, 05:16 PM |
| Q2 2020 | 32 | $311M | +$122M | -$29M | +$93.5M | FMTX, SWTX, ODTC, PRNB, ICPT | 13F-HR | 8/14/2020, 04:01 PM |
| Q1 2020 | 28 | $174M | +$27.2M | -$1.7M | +$25.5M | ICPT, PRNB, SWTX, ODTC, ALLK | 13F-HR | 5/15/2020, 03:58 PM |
| Q4 2019 | 19 | $209M | +$21.9M | -$17.1M | +$4.79M | ICPT, SWTX, ALLK, ODTC, PRNB | 13F-HR | 2/18/2020, 12:46 PM |
| Q3 2019 | 18 | $147M | +$21.6M | -$18.2M | +$3.39M | ICPT, ALLK, SYRS, SWTX, ODTC | 13F-HR | 11/14/2019, 04:38 PM |
| Q2 2019 | 21 | $151M | +$32.1M | -$4.66M | +$27.5M | ICPT, ODTC, ALLK, SYRS, STRO | 13F-HR | 8/14/2019, 04:00 PM |
| Q1 2019 | 18 | $127M | +$19.1M | -$6.8M | +$12.3M | ICPT, ALLK, ODTC, PRNB, STRO | 13F-HR | 5/15/2019, 05:22 PM |
| Q4 2018 | 17 | $104M | $0 | $0 | ALLK, ICPT, PRNB, STRO, ODTC | 13F-HR | 2/14/2019, 04:20 PM |